Optimi Health Corp.
Shares
3.22M shares
Listing Price
$5.50
Probable listing
May 20, 2026
Sector
Healthcare
About
Optimi Health Corp.
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners.
The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets.
Optimi Health Corp. Overview
Ticker, listing venue and issuer profile
Offer & Key Dates
Pricing terms and IPO milestones
Live Market Snapshot
Real-time price and trading activity
USD · NASDAQ:NASDAQ:OPTH
Valuation & Multiples
Key valuation ratios and metrics
Financial Health
Balance sheet strength and liquidity
Risk Metrics
Volatility versus the market
Financial Highlights
Historical financial performance
Historical Data
Market history and supplemental quote data
| Date | Open | High | Low | Close | Adj. Close | Change | Volume |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | $5.70 | $6.08 | $5.60 | $5.97 | $5.97 | +0.27 | 145,700 |
| 2026-05-28 | $5.57 | $5.75 | $5.54 | $5.65 | $5.65 | +0.08 | 25,400 |
| 2026-05-27 | $5.82 | $5.82 | $5.46 | $5.51 | $5.51 | -0.31 | 21,400 |
| 2026-05-26 | $5.80 | $5.91 | $5.37 | $5.71 | $5.71 | -0.09 | 113,200 |
| 2026-05-22 | $5.45 | $6.12 | $5.45 | $5.85 | $5.85 | +0.40 | 477,900 |
| 2026-05-21 | $5.51 | $5.82 | $4.95 | $5.70 | $5.70 | +0.19 | 468,200 |
| 2026-05-20 | $5.50 | $6.40 | $5.20 | $6.08 | $6.08 | +0.58 | 2,237,900 |
SEC Filings
Official documents from SEC EDGAR
No SEC filings available for this IPO yet.
Company Info
Contact and headquarters details
Leadership
Key executives and officers
Dane Stevens
Co-Founder, Chief Executive Officer, Chief Marketing Officer and Director
John James Wilson
Co-Founder and Chairman
Bryan Edward Safarik
Co-Founder, Chief Operating Officer and Director
Dr. Preston A. Chase
Chief Science Officer
Ann Little
Human Resources Manager
Leah Hodges
Corporate Secretary
